Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Sep;116(3):619-624.
doi: 10.1097/AOG.0b013e3181edac6b.

Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial

Kemal Güngördük  1 , Osman Asicioglu, Berhan Besimoglu, Ozgu Celikkol Güngördük, Gokhan Yildirm, Cemal Ark, Ali Ismet Tekirdağ
Affiliations
Randomized Controlled Trial

Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial

Kemal Güngördük et al. Obstet Gynecol. 2010 Sep.

Abstract

Objective: To estimate the efficacy of the routine use of intraumbilical vein injection of oxytocin with active management of the third stage of labor in reducing blood loss and length of the third stage.

Methods: In this prospective, randomized, double-blind trial, 412 women undergoing vaginal delivery who did not have risk factors for postpartum hemorrhage were randomly allocated to receive either 20 international units oxytocin diluted with 26 mL saline (n=207) or 30 mL saline (n=205) by intraumbilical vein injection. Active management of the third stage of labor (prophylactic injection of 10 international units oxytocin within 2 minutes of birth, early clamping of the umbilical cord, and controlled cord traction) was used in both groups. The primary outcome was mean blood loss during the third and fourth stages of labor.

Results: The mean estimated blood loss was significantly lower in women treated with oxytocin compared with women in the placebo group (195.3+/-81.0 mL compared with 288.3+/-134.1 mL, respectively; P<.001). The third stage of labor was significantly shorter in the oxytocin group than in the placebo group (4.5+/-1.6 minutes compared with 7.9+/-3.4 minutes, respectively; P<.001). The percentages of placentas remaining undelivered beyond 15 minutes were 0% in the oxytocin group and 4.4% in the placebo group (P=.002).

Conclusion: The use of intraumbilical injection of oxytocin with the active management of the third stage of labor significantly reduced postpartum blood loss and the duration of the third stage.

Clinical trial registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01094028.

Level of evidence: I.

PubMed Disclaimer

References

    1. Chamberlain GVP. The clinical aspects of massive haemorrhage. In: Patel N, editor. Maternal mortality—the way forward. London (UK): Royal College of Obstetricians and Gynaecologists; 1992. p. 54–62.
    1. World Health Organization. The prevention and management of postpartum haemorrhage. Report of a technical working group. Geneva (Switzerland): WHO; 1990.
    1. Weeks A. The retained placenta. Best Pract Res Clin Obstet Gynaecol 2008;22:1103–17.
    1. World Health Organization. WHO recommendations for the prevention of post partum haemorrhage. Geneva (Switzerland): WHO; 2006.
    1. Neri A, Goldman J, Gans B. Intra-umbilical vein injection of Pitocin. A new method in the management of the third stage of labor. Harefuah 1966;70:351–3.

Publication types

Associated data